Jia Huo Selected Research

RX 0047

7/2019

Azoreductase-Responsive Metal-Organic Framework-Based Nanodrug for Enhanced Cancer Therapy via Breaking Hypoxia-induced Chemoresistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jia Huo Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 11/2017
4	Inflammation (Inflammations) 12/2021 - 02/2016
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 02/2016
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2016
2	Femoral Fractures (Femoral Fracture) 04/2021 - 01/2019
2	Obesity 01/2019 - 01/2017
1	Extranodal NK-T-Cell Lymphoma 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Papillary Thyroid Cancer 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Disease Progression 12/2021
1	Osteoporosis 04/2021
1	Amyloidosis 01/2021
1	Hypoxia (Hypoxemia) 07/2019
1	Benign Familial Pemphigus (Hailey Hailey Disease) 01/2019
1	Dermatitis 01/2019
1	Reperfusion Injury 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Spinal Cord Ischemia 01/2017
1	Carcinogenesis 12/2016
1	Acute Lung Injury 01/2016
1	Erythema 01/2016
1	Dyschromatosis symmetrica hereditaria 1 03/2011

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2016
2	Biological ProductsIBA 01/2022 - 11/2017
2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2019 - 09/2017
2	Imiquimod (Aldara)FDA LinkGeneric 01/2019 - 02/2016
1	Long Noncoding RNAIBA 01/2022
1	Circular RNAIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	LuciferasesIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Sp1 Transcription FactorIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021
1	Simvastatin (Zocor)FDA LinkGeneric 12/2021
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 12/2021
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 12/2021
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	CurcuminIBA 01/2021
1	Semaphorin-3AIBA 01/2020
1	Metal-Organic FrameworksIBA 07/2019
1	azoreductaseIBA 07/2019
1	RX 0047IBA 07/2019
1	Pharmaceutical PreparationsIBA 07/2019
1	Oxygen (Dioxygen)IBA 07/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2019
1	Small Interfering RNA (siRNA)IBA 07/2019
1	Cannabinoid Receptor AgonistsIBA 01/2019
1	AdipokinesIBA 01/2019
1	ProteomeIBA 01/2019
1	extracellular matrix receptorIBA 01/2019
1	CannabinoidsIBA 09/2017
1	coenzyme Q10 (CoQ10)IBA 01/2017
1	lipoxin A4IBA 01/2017
1	HMGB1 Protein (HMG1)IBA 01/2017
1	LipidsIBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2017
1	CateninsIBA 10/2016
1	Transcription Factor 7-Like 2 ProteinIBA 10/2016
1	Cyclin D1IBA 10/2016
1	amentoflavoneIBA 02/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	sivelestatIBA 01/2016
1	InterleukinsIBA 01/2016
1	SodiumIBA 01/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Interleukin-23 (Interleukin 23)IBA 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2016
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2016
1	Adenosine DeaminaseIBA 03/2011
1	Double-Stranded RNA (RNA, Double Stranded)IBA 03/2011

Therapy/Procedure

1	Reoperation 04/2021
1	Drug Therapy (Chemotherapy) 07/2019
1	Therapeutics 07/2019
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2019
1	Electroacupuncture 01/2017
1	Catheters 01/2017